Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Voyager Therapeutics at Stifel 2026 CNS Forum: Year of Tau Focus
Voyager Therapeutics presented its strategic vision at the Stifel 2026 Virtual CNS Forum, focusing on its “year of tau” with ambitious plans to advance tau-targeting assets and novel capsid technology. The company intends to file an IND for its tau knockdown gene therapy in Q2 2026 and aims to demonstrate proof of concept for its capsids and shuttle technology through clinical trials next year. Voyager is pursuing partnerships with major pharmaceutical companies like Neurocrine, Novartis, and AstraZeneca to leverage external expertise and resources for its programs.